Apolipoprotein E in schizophrenia: A French association study and meta-analysis

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 119 B, Issue 1, 2003, Pages 18-23

  Schürhoff, Franck ^a,e   Krebs, Marie Odile ^b   Szöke, Andrei ^a   Loze, Jean Yves ^a   Goldberger, Céline ^b   Quignon, Valérie ^d   Tignol, Jean ^c   Rouillon, Frédéric ^a   Laplanche, Jean Louis ^d   Leboyer, Marion ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c CENTRE HOSPITALIER CHARLES PERRENS   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e Hopital Albert Chenevier   (France)

Author keywords

Apolipoprotein E; Association study; Genetic; Meta analysis; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRANCE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIGENE FAMILY; MUTATION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

EID: 10744220565     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20007     Document Type: Article

References (53)

1. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG. 1996. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53:425-436.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. (DSM-IV). 4th edn. Washington DC: American Psychiatric Association.
3. Amouyel P, Vidal O, Launay JM, Laplanche JL. 1994. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344:1315-1318.
4. Arendt T, Schindler C, Brükner MK, Eschrich K, Bigl V, Zedlick D, Marcova L. 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J Neurosci 17: 516-529.
5. Arnold SE, Joo E, MartinoliMG, Roy N, TrojanowskiJQ, Gur RE, Cannon T, Price RA. 1997. Apolipoprotein E genotype in schizophrenia: Frequency, age at onset, and neuropathological features. Neuroreport 8:1523-1526.
6. Bickeböller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Perez-Tur J, Michon A, Dubois B, Ledoze F, Thomas-Antenion C, Pasquier F, Puel M, Demonet JF, Moreau O, Babron MC, Meulien D, Guez D, Chartier-Harlin MC, Frebourg T, Agid Y, Martinez M, Clerget-Darpoux F. 1996. Apolipoprotein E and Alzheimer disease: Genotype specific risks by age and sex. Am J Hum Genet 60:439-446.
7. Chen J, Hong CJ, Chiu HJ, Lin CY, Bai YM, Song HL, Lai HC, Tsai SJ. 1999. Apolipoprotein E genotype and schizophrenia. Biol Psychiatry 39:141-143.
8. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KA, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180-184.
9. Das HK, McPherson J, Brun GAP, Karathanasis SK, Breslow JL. 1985. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260:6240-6247.
10. Durany N, Riederer P, Cruz-Sanchez FF. 2000. Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatr Genet 10:73-77.
11. Fernandez T, Yan WL, Hamburger S, Rapoport JL, Saunders AM, Schapiro M, Ginns EI, Sidransky E. 1999. Apolipoprotein E alleles in childhoodonset schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 88:211-213.
12. Folstein MF, Folstein SE, Mc Hugh PR. 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
13. Hallman DM, Boerwinkle E, Saha N, Sandholzer G, Csazar A, Utermann G. 1991. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49:338-339.
14. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM. 1995. Apolipoprotein E type 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett 202:101-104.
15. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
16. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, Lee KY, Sim CB. 1996. ε4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 46:1749-1751.
17. Hong CJ, Yu Younger WY, Lin CH, Song HL, Lai HC, Yang KH, Tsai SJ. 2000. Association study of apolipoprotein E ε4 with clinical phenotype and clozapine response in schizophrenia. Biol Psychiatry 42:172-174.
18. Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S, Takamatsu J, Miyakawa T. 1997. Apolipoprotein E genotype and psychosis. Biol Psychiatry 41:906-908.
19. Johnson G, Brane D, Block W, Kammen DP van, Gurklis J, Peters JL, Wyatt RJ, Kirck DG, Ghanbari HA, Merril CR. 1992. Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theor Electrophor 3:47-53.
20. Joober R, Rouleau G, Fon E, Lal S, Palmour R, Bloom D, Labelle A, Benkelfat C. 1996. Apolipoprotein E genotype in schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 67:235.
21. Jönsson E, Lannfelt L, Engvall B, Sedvall G. 1996. Lack of association between schizophrenia and the apolipoprotein E ε4 allele. Eur Arch Psychiatry Clin Neurosci 246:182-184.
22. Kalman J, Kudchodkar BJ, Murray K, McConathy WJ, Juhasz A, Janka Z, Lacko AG. 1999. Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease. Dement Geriatr Cogn Disord 10:488-493.
23. Kendler KS, Diehl SR. 1993. The genetics of schizophrenia: A current, genetic-epidemiologic perspective. Schizophr Bull 19:261-285.
24. Kimura T, Yokota S, Shono M, Igata-Yi R, Takamatsu J, Miyakawa T. 1997a. Apolipoprotein E ε4 and schizophrenia. Neuroreport 8:17.
25. Kimura T, Yokota S, Igata-Yi R, Shono M, Takamatsu J, Miyakawa T. 1997b. Apolipoprotein E ε2 allele and early onset schizophrenia. Neurosci Lett 231:53-55.
26. Kimura T, Shono M, Yokota S, Igata-Yi R, Takamatsu J, Miyakawa T. 2000a. Apolipoprotein E ε3 allele is not a risk factor of schizophrenia: A study of 314 Japanese patients. Biol Psychiatry 42:66-68.
27. Kimura T, Shono M, Yokota S, Ishizuka K, Watanabe M, Takamatsu J, Miyakawa T. 2000b. Apolipoprotein E ε4 and tardive dyskinesia in a Japanese population. J Psychiatr Res 34:329-332.
28. Lan TH, Hong CJ, Chen JY, Sim CB. 1997. Apolipoprotein E-ε4 frequency in patients with schizophrenia. Biol Psychiatry 42:225-227.
29. Mahadik SP, Mukherjee S. 1996. Free radical pathology and antioxidant defense in schizophrenia. Schizophr Res 19:1-17.
30. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
31. Martorell L, Virgos C, Valero J, Coll G, Figuera L, Joven J, Pocovi M, Labad A, Vilella E. 2001. Schizophrenic women with the ApoE ε4 allele have a worse prognosis than those without it. Mol Psychiatry 6:307-310.
32. Maxwell ME. 1992. Family Interview for Genetic Studies. Clinical Neurogenetic Branch, Intramural Research Program, NIMH.
33. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
34. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14:55-61.
35. Nathan BP, Bellosta S, Sanan A, Weisgraber KH, Mahley RW, Pitas RE. 1997. Differential effects of apolipoprotein ε3 and ε4 on neuronal growth in vivo. Science 264:850-852.
36. Nurnberger JI, Blehar MC, Kaufman CA, York-cooler C, Simpson SG, Harkavy-Freedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Arch Gen Psychiatry 51:849-864.
37. Ohara K, Nagai M, Ohara K. 1997. Apolipoprotein E ε4 and clinical phenotype in schizophrenia. Lancet 350:1857.
38. Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D. 1997. Apoliprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 350:930-931.
39. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. 1987. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:148-161.
40. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC. 1997. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition. Neurology 48:985-989.
41. Poirier J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS 17:525-530.
42. Powchik P, Friedman J, Haroutunian V, Greenberg D, Altsteil L, Purohit D, Perl D, Davidson M. 1997. Apolipoprotein E4 in schizophrenia: A study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 42:296-298.
43. Prohovnik I, Dwork AJ, Kaufman MA, Wilson N. 1993. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 19: 805-816.
44. Rietschel M, Kraunß H, Müller DJ, Nöthen MM, Macciardi F. 1997. Apolipoprotein E ε4 and clinical phenotype in schizophrenia. Lancet 350:1857-1858.
45. Saiz PA, Morales B, G-Portilla MP, Alvarez V, Coto E, Fernández JM, Bousoño M, Bobes J. 2002. Apolipoprotein E genotype and schizophrenia: Further negative evidence. Acta Psychiatr Scand 105:71-75.
46. Salem JE, Kring AM. 1998. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 18:795-819.
47. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hislop MD, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Growden J, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
48. Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM, Petruzzi M, Daneluzzo E, Ortenzi L, Piacentini S, Amaducci L. 1998. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci Lett 244:118-120.
49. Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfus S, Campion D, Frebourg T, Petit M. 1998. No association of apolipoprotein E epsilon 4 with schizophrenia even in cognitively impaired patients. Schizophr Res 30:149-153.
50. Thibaut F, Van der Elst A, Campion D, Martin C, Coron B, Dollfus S, Frebourg TH, Petit M. 1999. Apolipoprotein E-ε4 frequency in deficit schizophrenia. Eur Psychiatry 14:148-151.
51. Town T, Fallin D, Crawford F, Walsh S, Solomon R, Mullan M. 1997. Lack of association between the apolipoprotein E ε4 allele (APOE ε4) and chronic schizophrenia. Am J Med genet (Neuropsychiatr Genet) 74:451-452.
52. Woolf B. 1955. On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
53. Zhu S, Nöthen MM, Uhlhaas S, Rietschel M, Körner J, Lanczik M, Fimmers R, Propping P. 1996. Apolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 6:75-79.